Stay updated on Eptinezumab Efficacy in Refractory Migraine Clinical Trial
Sign up to get notified when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.

Latest updates to the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page
- Check3 days agoChange DetectedNew revision v3.6.6 was added to the study history. The previous v3.6.5 entry was removed, updating the page's version history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecord History now includes new sections and controls (Compare, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Status) and lists dated version entries. This change enhances the ability to review and compare how the study record has evolved over time by exposing key data sections in the history view.SummaryDifference21%

- Check24 days agoChange DetectedA new revision entry (v3.6.5) was added to the study history, replacing the previous revision (v3.6.4), reflecting an update to the page metadata.SummaryDifference0.1%

- Check39 days agoChange DetectedThe Record History page updated its site revision label from v3.6.3 to v3.6.4, indicating a platform version update included in the page. This reflects maintenance work rather than changes to the study record itself.SummaryDifference0.1%

- Check60 days agoChange DetectedThe Study Record History now shows a new revision entry v3.6.3, superseding the previous v3.6.2, indicating an update to the page data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe record history now includes a new revision entry (v3.6.2) and removes the previous v3.6.0, updating the page's revision metadata.SummaryDifference0.1%

Stay in the know with updates to Eptinezumab Efficacy in Refractory Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eptinezumab Efficacy in Refractory Migraine Clinical Trial page.